Should I buy or sell Rockwell Medical stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" RMTI shares. View RMTI analyst ratings or view top-rated stocks .

What is Rockwell Medical's stock price target for 2024?

2 equities research analysts have issued 1-year target prices for Rockwell Medical's stock. Their RMTI share price targets range from $5.00 to $9.00. On average, they expect the company's share price to reach $7.00 in the next twelve months. This suggests a possible upside of 382.8% from the stock's current price. View analysts price targets for RMTI or view top-rated stocks among Wall Street analysts .

How have RMTI shares performed in 2024?

Rockwell Medical's stock was trading at $1.89 at the beginning of 2024. Since then, RMTI shares have decreased by 23.3% and is now trading at $1.45. View the best growth stocks for 2024 here .

When is Rockwell Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our RMTI earnings forecast .

How can I listen to Rockwell Medical's earnings call?

Rockwell Medical will be holding an earnings conference call on Tuesday, May 14th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link .

How were Rockwell Medical's earnings last quarter?

Rockwell Medical, Inc. (NASDAQ:RMTI) posted its quarterly earnings results on Thursday, March, 21st. The company reported $0.02 earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.10. The business earned $22.09 million during the quarter, compared to analyst estimates of $22.09 million. Rockwell Medical had a negative net margin of 10.09% and a negative trailing twelve-month return on equity of 39.17%.

When did Rockwell Medical's stock split?

Rockwell Medical's stock reverse split before market open on Friday, May 13th 2022. The 1-11 reverse split was announced on Friday, May 13th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split.

What guidance has Rockwell Medical issued on next quarter's earnings?

Rockwell Medical issued an update on its FY 2024 earnings guidance on Thursday, March, 21st. The company provided EPS guidance of for the period. The company issued revenue guidance of $84.0 million-$88.0 million, compared to the consensus revenue estimate of $98.0 million.

What is Robert L. Chioini's approval rating as Rockwell Medical's CEO?

6 employees have rated Rockwell Medical Chief Executive Officer Robert L. Chioini on Glassdoor.com . Robert L. Chioini has an approval rating of 22% among the company's employees. This puts Robert L. Chioini in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Rockwell Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rockwell Medical investors own include Immunomedics (IMMU) , JinkoSolar (JKS) , Seagen (SGEN) , Geron (GERN) , OPKO Health (OPK) , Amarin (AMRN) , Gilead Sciences (GILD) , ImmunoGen (IMGN) , Sorrento Therapeutics (SRNE) and VBI Vaccines (VBIV) .

How do I buy shares of Rockwell Medical?

Shares of RMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:RMTI

Rockwell Medical (RMTI) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free RMTI Stock Alerts

$1.45

-0.03 (-2.03%)

(As of 05:21 PM ET)

Compare

Today's Range: $1.45
▼
$1.50
50-Day Range: $1.26
▼
$1.71
52-Week Range: $1.16
▼
$6.24

Volume: 81,513 shs
Average Volume: 218,211 shs
Market Capitalization: $42.58 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $7.00

Get Rockwell Medical alerts:

Rockwell Medical MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 382.8% Upside
$7.00 Price Target
Short Interest: Healthy
2.54% of Float Sold Short
Dividend Strength: N/A
Sustainability: -2.35
Upright™ Environmental Score
News Sentiment: 0.88
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.11) to $0.06 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.86 out of 5 stars

Medical Sector

199th out of 911 stocks

Pharmaceutical Preparations Industry

75th out of 411 stocks

3.5

Analyst's Opinion

Consensus Rating
Rockwell Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Rockwell Medical has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
2.54% of the float of Rockwell Medical has been sold short.
Short Interest Ratio / Days to Cover
Rockwell Medical has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Rockwell Medical has recently increased by 18.65%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Rockwell Medical does not currently pay a dividend.
Dividend Growth
Rockwell Medical does not have a long track record of dividend growth.

4.1

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Rockwell Medical has received a 58.29% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is false driven by its "Iron deficiency medication" and "Clinical research services for deficiency diseases" products. See details.
Environmental Sustainability
The Environmental Impact score for Rockwell Medical is -2.35.

3.3

News and Social Media Coverage

News Sentiment
Rockwell Medical has a news sentiment score of 0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Rockwell Medical this week, compared to 1 article on an average week.
Search Interest
Only 3 people have searched for RMTI on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
MarketBeat Follows
2 people have added Rockwell Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Rockwell Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 2.20% of the stock of Rockwell Medical is held by insiders.
Percentage Held by Institutions
Only 23.31% of the stock of Rockwell Medical is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Rockwell Medical are expected to grow in the coming year, from ($0.11) to $0.06 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Rockwell Medical is -3.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Rockwell Medical is -3.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Rockwell Medical has a P/B Ratio of 1.93. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About Rockwell Medical Stock (NASDAQ:RMTI)

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

RMTI Stock Price History

30 days | 90 days | 365 days | Advanced Chart

RMTI Stock News Headlines

April 17, 2024 | finance.yahoo.com

Rockwell Medical Continues to Expand its Distribution Capabilities in Western United States

April 16, 2024 | businesswire.com

Rockwell Medical to Release First Quarter 2024 Results on Tuesday, May 14, 2024

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

April 4, 2024 | msn.com

Rockwell Medical gains as global reach widens

April 4, 2024 | businesswire.com

Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda

March 26, 2024 | finance.yahoo.com

Rockwell Medical Full Year 2023 Earnings: EPS Beats Expectations

March 25, 2024 | businesswire.com

Rockwell Medical Named 'Great Place to Work' for Second Year in a Row

March 24, 2024 | finance.yahoo.com

Analysts Have Been Trimming Their Rockwell Medical, Inc. (NASDAQ:RMTI) Price Target After Its Latest Report

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

March 23, 2024 | seekingalpha.com

Rockwell Medical, Inc. (RMTI) Q4 2023 Earnings Call Transcript

March 23, 2024 | markets.businessinsider.com

Buy Rating Reaffirmed for Rockwell Med amidst Strategic Growth and Operational Efficiency

March 22, 2024 | finance.yahoo.com

Q4 2023 Rockwell Medical Inc Earnings Call

March 21, 2024 | benzinga.com

Rockwell Medical: Q4 Earnings Insights

March 21, 2024 | marketwatch.com

Rockwell Medical Shares Rise After Narrower 4Q Loss, Higher Sales

March 21, 2024 | msn.com

RMTI Stock Earnings: Rockwell Medical Beats EPS, Misses Revenue for Q4 2023

March 21, 2024 | sfgate.com

Rockwell Medical: Q4 Earnings Snapshot

March 21, 2024 | businesswire.com

Rockwell Medical Achieves Profitability on an Adjusted EBITDA Basis in the Fourth Quarter 2023 and Record Net Sales, Gross Profit and Gross Margin for the Full-Year 2023

March 20, 2024 | markets.businessinsider.com

Rockwell Medical earnings preview: what Wall Street is expecting

March 18, 2024 | markets.businessinsider.com

Rockwell Medical Inc Registered Shs hosts conference call for investors

February 14, 2024 | finance.yahoo.com

Rockwell Medical (RMTI) Flat As Market Gains: What You Should Know

February 8, 2024 | finance.yahoo.com

Rockwell Medical to Release Fourth Quarter and Full-Year 2023 Results on Thursday, March 21, 2024

January 23, 2024 | morningstar.com

Rockwell Medical Inc RMTI

January 8, 2024 | msn.com

Rockwell Medical provides Q4 and fiscal 2023 forecast

January 8, 2024 | finance.yahoo.com

Rockwell Medical Amends Loan and Security Agreement with Innovatus Life Sciences Lending Fund

December 21, 2023 | benzinga.com

Rockwell Medical Stock (NASDAQ:RMTI) Dividends: History, Yield and Dates

November 30, 2023 | seekingalpha.com

Returning To Rockwell Medical: Buy At 65% Of Revenue

November 17, 2023 | finance.yahoo.com

Rockwell Medical, Inc. (NASDAQ:RMTI): Are Analysts Optimistic?

See More Headlines

Receive RMTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rockwell Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/21/2024
Today: 4/19/2024
Next Earnings (Confirmed): 5/14/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: Health Care Equipment
Current Symbol: NASDAQ:RMTI
CUSIP: 77437410
CIK: 1041024
Web: www.rockwellmed.com
Phone: (248) 432-1362
Fax: 248-960-9119
Employees: 237
Year Founded: 1995

Price Target and Rating

Average Stock Price Target: $7.00
High Stock Price Target: $9.00
Low Stock Price Target: $5.00
Potential Upside/Downside: +373.0%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.40)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-8,440,000.00
Net Margins: -10.09%
Pretax Margin: -10.09%
Return on Equity: -39.17%
Return on Assets: -13.87%

Debt

Debt-to-Equity Ratio: 0.46
Current Ratio: 1.73
Quick Ratio: 1.38

Sales & Book Value

Annual Sales: $83.61 million
Price / Sales: 0.52
Cash Flow: $0.02 per share
Price / Cash Flow: 76.25
Book Value: $0.75 per share
Price / Book: 1.97

Miscellaneous

Outstanding Shares: 29,360,000
Free Float: 28,719,000
Market Cap: $43.45 million
Optionable: Optionable
Beta: 1.17

Social Links

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Dr. Mark Strobeck Ph.D. (Age 53)
President, CEO & Director
Comp: $643.41k
Ms. Megan C. Timmins (Age 51)
Executive VP, Chief Legal Officer & Secretary
Comp: $518.09k
Mr. James A. McCarthy
Senior Vice President of Business & Corporate Development
Mr. Timothy T. Chole
Senior Vice President of Sales & Marketing
Ms. Heather R. Hunter
Senior VP & Chief Corporate Affairs Officer
Mr. Jason Finkelstein
Investor Relations Representative

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

RMTI Stock Analysis - Frequently Asked Questions

Should I buy or sell Rockwell Medical stock right now?: 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" RMTI shares.
View RMTI analyst ratings or view top-rated stocks.
What is Rockwell Medical's stock price target for 2024?: 2 equities research analysts have issued 1-year target prices for Rockwell Medical's stock. Their RMTI share price targets range from $5.00 to $9.00. On average, they expect the company's share price to reach $7.00 in the next twelve months. This suggests a possible upside of 382.8% from the stock's current price.
View analysts price targets for RMTI or view top-rated stocks among Wall Street analysts.
How have RMTI shares performed in 2024?: Rockwell Medical's stock was trading at $1.89 at the beginning of 2024. Since then, RMTI shares have decreased by 23.3% and is now trading at $1.45.
View the best growth stocks for 2024 here.
When is Rockwell Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our RMTI earnings forecast.
How can I listen to Rockwell Medical's earnings call?: Rockwell Medical will be holding an earnings conference call on Tuesday, May 14th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.
How were Rockwell Medical's earnings last quarter?: Rockwell Medical, Inc. (NASDAQ:RMTI) posted its quarterly earnings results on Thursday, March, 21st. The company reported $0.02 earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.10. The business earned $22.09 million during the quarter, compared to analyst estimates of $22.09 million. Rockwell Medical had a negative net margin of 10.09% and a negative trailing twelve-month return on equity of 39.17%.

When did Rockwell Medical's stock split?: Rockwell Medical's stock reverse split before market open on Friday, May 13th 2022. The 1-11 reverse split was announced on Friday, May 13th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split.
What guidance has Rockwell Medical issued on next quarter's earnings?: Rockwell Medical issued an update on its FY 2024 earnings guidance on Thursday, March, 21st. The company provided EPS guidance of for the period. The company issued revenue guidance of $84.0 million-$88.0 million, compared to the consensus revenue estimate of $98.0 million.
What is Robert L. Chioini's approval rating as Rockwell Medical's CEO?: 6 employees have rated Rockwell Medical Chief Executive Officer Robert L. Chioini on Glassdoor.com. Robert L. Chioini has an approval rating of 22% among the company's employees. This puts Robert L. Chioini in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Rockwell Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Rockwell Medical investors own include Immunomedics (IMMU), JinkoSolar (JKS), Seagen (SGEN), Geron (GERN), OPKO Health (OPK), Amarin (AMRN), Gilead Sciences (GILD), ImmunoGen (IMGN), Sorrento Therapeutics (SRNE) and VBI Vaccines (VBIV).
How do I buy shares of Rockwell Medical?: Shares of RMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:RMTI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial